The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

The Market’s Momentum: Growth Insights

• Strong growth from $48.26 billion in 2023 to $52.61 billion in 2024.
• Compound annual growth rate (CAGR) of 9.0% attributed to hemophilia, geriatric population, awareness, and surgical procedures.
• Forecasted growth to $75 billion in 2028 with a CAGR of 9.3%.
• Predicted factors: rare diseases therapies, chronic diseases, healthcare expenditure, patient-centric treatment, and healthcare infrastructure.

Surging Demand for Blood Plasma Derivatives Driven by Immune Deficiency Disorders

• Increasing prevalence of immunodeficiency disorders propels market growth.
• Blood plasma derivatives crucial in treating immune deficiency conditions.
• Example: Global hunger impacting malnutrition and immune deficiency.
• Market players: Bayer, Sanofi, Takeda, Baxter, CSL, and others leading the charge.

Read More On The Blood Plasma Derivatives Market Report 2024 – https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Strategic Partnerships for Enhanced Access and Supply

• Focus on strategic partnerships to ensure access and supply of immunoglobulins.
• Example: Kedrion S.p.A. partners with LPB to produce immunoglobulins in Hungary using LFB plasma from France.
• Partnerships aimed at meeting increasing demand for plasma-derived medications.

Grifols S.A. Expands Product Line Through Biotest AG Acquisition

• Grifols S.A. acquires Biotest AG to enhance plasma medicine availability.
• Acquisition accelerates and expands product line, drives revenue growth.
• Biotest AG contributes extensive European network of plasma facilities.
• Example: Grifols S.A., a leader in plasma-derived medicines, expands its market presence.

Segmenting the Market

• Types: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types.
• Applications: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications.
• End-Users: Hospitals, Clinics, Other End-Users.

Regional Dynamics

• North America leads the market in 2023.
• Regional trends influencing market dynamics.

Conclusion: Pioneering Healthcare Solutions

The blood plasma derivatives market emerges as a cornerstone in addressing immune deficiency disorders and advancing healthcare solutions globally. With strategic partnerships, acquisitions, and technological advancements, companies are poised to meet the increasing demand for plasma-derived medications. As the prevalence of chronic diseases rises and healthcare expenditure increases, the market continues to expand, driven by patient-centric approaches and advancements in healthcare infrastructure. Through collaboration and innovation, the future of blood plasma derivatives promises to revolutionize treatment approaches, ensuring improved patient outcomes and quality of life worldwide. As we embark on this journey, the blood plasma derivatives market stands at the forefront of healthcare innovation, shaping a healthier and more resilient future for all.

Request for A Sample Of The Global Blood Plasma Derivatives Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=12107&type=smp